Biodegradable microparticles for in vivo glomerular targeting: Implications for gene therapy of glomerular disease

N. Stanley Nahman, Wm Tod Drost, Udayan Y. Bhatt, Thomas J. Sferra, Amy Johnson, Pablo Gamboa, George H. Hinkle, Aaron Haynam, Valerie Bergdall, Christopher Hickey, John D. Bonagura, Lisa Brannon-Peppas, Jonathan S. Ellison, Abigail Mansfield, Scott Shie, Na Shen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Glomerular disease is the most common cause of kidney failure in the United States. Gene therapy represents a novel approach to the treatment of diseases of the glomerulus, but necessitates safe and accurate tissue targeting, combined with efficient gene transfer into the cells of interest. Our previous work demonstrated effective glomerular gene transfer after arterial injection of replication deficient recombinant adenovirus complexed to 16 μm polystyrene microspheres. The insoluble nature of polystyrene makes glomerular ischemia a potential complication of the procedure. On this basis, we postulated that biodegradable gelatin particles could serve as transport vehicles in this system. To address this question, we assessed the in vivo degradation of Tc-99m labeled gelatin or polystyrene particles in the kidney following selective renal artery injection. Radioactivity declined 2-3 fold faster in a gelatin-injected pig kidney, when compared to polystyrene injected animals. The discrepancy in signal loss between gelatin and polystyrene injected animals could not be explained by differences in the rate of dissociation of Tc-99m from each particle type, and suggest that gelatin particles degrade once lodged in the glomerular capillary. These data suggest that biodegradable gelatin particles may help to minimize ischemic potential when used to shuttle therapeutic DNA to the glomerulus.

Original languageEnglish (US)
Pages (from-to)189-195
Number of pages7
JournalBiomedical Microdevices
Volume4
Issue number3
DOIs
StatePublished - Aug 8 2002

Fingerprint

Gene therapy
Gelatin
Genetic Therapy
Polystyrenes
Gene transfer
Animals
Radioactivity
Kidney
Injections
Microspheres
Renal Artery
Adenoviridae
DNA
Genes
Renal Insufficiency
Tissue
Swine
Ischemia
Degradation
Therapeutics

Keywords

  • Biodegradable particles
  • Gelatin
  • Gene therapy
  • Glomerulus
  • Kidney failure

ASJC Scopus subject areas

  • Biomedical Engineering
  • Molecular Biology

Cite this

Biodegradable microparticles for in vivo glomerular targeting : Implications for gene therapy of glomerular disease. / Nahman, N. Stanley; Drost, Wm Tod; Bhatt, Udayan Y.; Sferra, Thomas J.; Johnson, Amy; Gamboa, Pablo; Hinkle, George H.; Haynam, Aaron; Bergdall, Valerie; Hickey, Christopher; Bonagura, John D.; Brannon-Peppas, Lisa; Ellison, Jonathan S.; Mansfield, Abigail; Shie, Scott; Shen, Na.

In: Biomedical Microdevices, Vol. 4, No. 3, 08.08.2002, p. 189-195.

Research output: Contribution to journalArticle

Nahman, NS, Drost, WT, Bhatt, UY, Sferra, TJ, Johnson, A, Gamboa, P, Hinkle, GH, Haynam, A, Bergdall, V, Hickey, C, Bonagura, JD, Brannon-Peppas, L, Ellison, JS, Mansfield, A, Shie, S & Shen, N 2002, 'Biodegradable microparticles for in vivo glomerular targeting: Implications for gene therapy of glomerular disease', Biomedical Microdevices, vol. 4, no. 3, pp. 189-195. https://doi.org/10.1023/A:1016044313036
Nahman, N. Stanley ; Drost, Wm Tod ; Bhatt, Udayan Y. ; Sferra, Thomas J. ; Johnson, Amy ; Gamboa, Pablo ; Hinkle, George H. ; Haynam, Aaron ; Bergdall, Valerie ; Hickey, Christopher ; Bonagura, John D. ; Brannon-Peppas, Lisa ; Ellison, Jonathan S. ; Mansfield, Abigail ; Shie, Scott ; Shen, Na. / Biodegradable microparticles for in vivo glomerular targeting : Implications for gene therapy of glomerular disease. In: Biomedical Microdevices. 2002 ; Vol. 4, No. 3. pp. 189-195.
@article{7b51d4fd9ea34aac83c2d9b12f49bf2d,
title = "Biodegradable microparticles for in vivo glomerular targeting: Implications for gene therapy of glomerular disease",
abstract = "Glomerular disease is the most common cause of kidney failure in the United States. Gene therapy represents a novel approach to the treatment of diseases of the glomerulus, but necessitates safe and accurate tissue targeting, combined with efficient gene transfer into the cells of interest. Our previous work demonstrated effective glomerular gene transfer after arterial injection of replication deficient recombinant adenovirus complexed to 16 μm polystyrene microspheres. The insoluble nature of polystyrene makes glomerular ischemia a potential complication of the procedure. On this basis, we postulated that biodegradable gelatin particles could serve as transport vehicles in this system. To address this question, we assessed the in vivo degradation of Tc-99m labeled gelatin or polystyrene particles in the kidney following selective renal artery injection. Radioactivity declined 2-3 fold faster in a gelatin-injected pig kidney, when compared to polystyrene injected animals. The discrepancy in signal loss between gelatin and polystyrene injected animals could not be explained by differences in the rate of dissociation of Tc-99m from each particle type, and suggest that gelatin particles degrade once lodged in the glomerular capillary. These data suggest that biodegradable gelatin particles may help to minimize ischemic potential when used to shuttle therapeutic DNA to the glomerulus.",
keywords = "Biodegradable particles, Gelatin, Gene therapy, Glomerulus, Kidney failure",
author = "Nahman, {N. Stanley} and Drost, {Wm Tod} and Bhatt, {Udayan Y.} and Sferra, {Thomas J.} and Amy Johnson and Pablo Gamboa and Hinkle, {George H.} and Aaron Haynam and Valerie Bergdall and Christopher Hickey and Bonagura, {John D.} and Lisa Brannon-Peppas and Ellison, {Jonathan S.} and Abigail Mansfield and Scott Shie and Na Shen",
year = "2002",
month = "8",
day = "8",
doi = "10.1023/A:1016044313036",
language = "English (US)",
volume = "4",
pages = "189--195",
journal = "Biomedical Microdevices",
issn = "1387-2176",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Biodegradable microparticles for in vivo glomerular targeting

T2 - Implications for gene therapy of glomerular disease

AU - Nahman, N. Stanley

AU - Drost, Wm Tod

AU - Bhatt, Udayan Y.

AU - Sferra, Thomas J.

AU - Johnson, Amy

AU - Gamboa, Pablo

AU - Hinkle, George H.

AU - Haynam, Aaron

AU - Bergdall, Valerie

AU - Hickey, Christopher

AU - Bonagura, John D.

AU - Brannon-Peppas, Lisa

AU - Ellison, Jonathan S.

AU - Mansfield, Abigail

AU - Shie, Scott

AU - Shen, Na

PY - 2002/8/8

Y1 - 2002/8/8

N2 - Glomerular disease is the most common cause of kidney failure in the United States. Gene therapy represents a novel approach to the treatment of diseases of the glomerulus, but necessitates safe and accurate tissue targeting, combined with efficient gene transfer into the cells of interest. Our previous work demonstrated effective glomerular gene transfer after arterial injection of replication deficient recombinant adenovirus complexed to 16 μm polystyrene microspheres. The insoluble nature of polystyrene makes glomerular ischemia a potential complication of the procedure. On this basis, we postulated that biodegradable gelatin particles could serve as transport vehicles in this system. To address this question, we assessed the in vivo degradation of Tc-99m labeled gelatin or polystyrene particles in the kidney following selective renal artery injection. Radioactivity declined 2-3 fold faster in a gelatin-injected pig kidney, when compared to polystyrene injected animals. The discrepancy in signal loss between gelatin and polystyrene injected animals could not be explained by differences in the rate of dissociation of Tc-99m from each particle type, and suggest that gelatin particles degrade once lodged in the glomerular capillary. These data suggest that biodegradable gelatin particles may help to minimize ischemic potential when used to shuttle therapeutic DNA to the glomerulus.

AB - Glomerular disease is the most common cause of kidney failure in the United States. Gene therapy represents a novel approach to the treatment of diseases of the glomerulus, but necessitates safe and accurate tissue targeting, combined with efficient gene transfer into the cells of interest. Our previous work demonstrated effective glomerular gene transfer after arterial injection of replication deficient recombinant adenovirus complexed to 16 μm polystyrene microspheres. The insoluble nature of polystyrene makes glomerular ischemia a potential complication of the procedure. On this basis, we postulated that biodegradable gelatin particles could serve as transport vehicles in this system. To address this question, we assessed the in vivo degradation of Tc-99m labeled gelatin or polystyrene particles in the kidney following selective renal artery injection. Radioactivity declined 2-3 fold faster in a gelatin-injected pig kidney, when compared to polystyrene injected animals. The discrepancy in signal loss between gelatin and polystyrene injected animals could not be explained by differences in the rate of dissociation of Tc-99m from each particle type, and suggest that gelatin particles degrade once lodged in the glomerular capillary. These data suggest that biodegradable gelatin particles may help to minimize ischemic potential when used to shuttle therapeutic DNA to the glomerulus.

KW - Biodegradable particles

KW - Gelatin

KW - Gene therapy

KW - Glomerulus

KW - Kidney failure

UR - http://www.scopus.com/inward/record.url?scp=0036313056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036313056&partnerID=8YFLogxK

U2 - 10.1023/A:1016044313036

DO - 10.1023/A:1016044313036

M3 - Article

AN - SCOPUS:0036313056

VL - 4

SP - 189

EP - 195

JO - Biomedical Microdevices

JF - Biomedical Microdevices

SN - 1387-2176

IS - 3

ER -